GIX01 Supplementary Materials
For further study in this topic, please consider viewing additional modules, listed on our home page 

In addition, the following materials may be of interest:

Fichna J, Bawa M, Thakur GA, Tichkule R, Makriyannis A, McCafferty DM, et al. Cannabinoids alleviate experimentally induced intestinal inflammation. PloS One. 2014; 9:1-9

Lahat A, Lang A, Ben-Horin S. Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: A pilot prospective study. Digestion. 2012;  85:1-8.

Lal S, Prasad N, Ryan M, Tangri S, Silverberg MS, Gordon A, et al. Cannabis use amongst patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011; 23:891-896.

Naftali T, Lev LB, Yablecovitch D, Half E, Konikoff FM. Treatment of Crohn’s disease with cannabis: an observational study. Isr Med Assoc J. 2011; 13:455-458.

Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky-Benjaminov F, Konikoff FM. Cannabis induces a clinical response in patients with Crohn’s disease: A prospective placebo-controlled study. Clin Gastroenterol Hepatol. 2013; 11:1276-1280.e1.